Get the Stockscreener App
4.14
4.83%
-0.21
Pre-market:
4.16
0.02
+0.48%
Aptevo Therapeutics Inc Stock (APVO) Forecast
The Aptevo Therapeutics Inc (APVO) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $1.9254, representing a -53.49% decrease from the current price of $4.14. The highest analyst price target is $1.6996, and the lowest is $2.1513.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month APVO Price Target
Average 26.21
(+533.04% Upside)
Is Aptevo Therapeutics Inc (APVO) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 36.42 | Neutral |
| STOCH(9,6) | 17.69 | Buy |
| STOCHRSI(14) | 30.68 | Neutral |
| MACD(12,26) | -0.4231 | Buy |
| ADX(14) | 18.10 | Neutral |
| William %R | -70.41 | Neutral |
| CCI(14) | -154.08 | Sell |
Buy: 2
Sell: 1
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
4.449
Sell
|
4.4118
Sell
|
| MA20 |
4.5825
Sell
|
4.6509
Sell
|
| MA50 |
6.2886
Sell
|
5.9103
Sell
|
| MA100 |
7.3019
Sell
|
12.08
Sell
|
| MA200 |
14.20
Sell
|
59.68
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, APVO could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 11 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on APVO, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 36.42 indicates that APVO is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 17.69 indicates that APVO is oversold. This indicates that APVO price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 30.68 indicates that APVO is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 18.1 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -154.08 indicates that APVO is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term APVO price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Aptevo Therapeutics Inc financial reports and earnings history, Aptevo Therapeutics Inc (APVO) stock could reach $10.16 by 2030, $6.9524 by 2040 and $20.15 by 2050. See the projected annual prices until 2050 of the Aptevo Therapeutics Inc stock below:
- Aptevo Therapeutics Inc (APVO) is expected to reach an average price of $3.3964 in 2035, with a high prediction of $3.5347 and a low estimate of $3.4089. This indicates an $-17.96% rise from the last recorded price of $4.14.
- Aptevo Therapeutics Inc (APVO) stock is projected to chart a bullish course in 2040, with an average price target of $6.7963, representing an $64.16% surge from its current level. The forecast ranges from a conservative $7.0543 to a sky-high $6.9524.
- Our analysts predict Aptevo Therapeutics Inc (APVO) to jump 213.89% by 2045, soaring from $12.80 to an average price of $13.00, potentially reaching $12.78. While $12.80 is the low estimate, the potential upside is significant.
- Aptevo Therapeutics Inc (APVO) stock is expected to climb by 2050, reaching an average of $20.23, a $388.66% jump from its current level. However, a wide range of estimates exists, with high and low targets of $20.15 and $20.38, respectively, highlighting the market's uncertainty.
Aptevo Therapeutics Inc Stock (APVO) Year by Year Forecast
Aptevo Therapeutics Inc Stock (APVO) Price Forecast for 2025
Aptevo Therapeutics Inc Stock (APVO) is expected to reach an average price of $2.5638 in 2025, with a high prediction of $5.101 and a low estimate of $0.0267. This indicates an -38.07% fall from the last recorded price of $4.14.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| March, 2025 | $2.8345 | $2.1513 | $1.6996 | -31.53% |
| April, 2025 | $5.1499 | $3.8966 | $4.4052 | +24.39% |
| May, 2025 | $4.7901 | $4.7901 | $5.101 | +15.70% |
| June, 2025 | $3.0885 | $2.9885 | $3.1998 | -25.40% |
| July, 2025 | $2.3251 | $2.8831 | $2.1851 | -43.84% |
| August, 2025 | $0.5744 | $0.1197 | $2.9776 | -86.13% |
| September, 2025 | $0.2563 | $0.1164 | $1.051 | -93.81% |
| October, 2025 | $0.1103 | $0.0267 | $0.9217 | -97.34% |
| November, 2025 | $0.2396 | $0.3151 | $0.3349 | -94.21% |
| December, 2025 | $1.2162 | $0.3869 | $0.5868 | -70.62% |
Aptevo Therapeutics Inc Stock (APVO) Price Forecast for 2026
The predicted value for Aptevo Therapeutics Inc (APVO) in 2026 is set at an average of $26.89. Estimates vary from a peak of $52.39 to a trough of $1.3935, indicating an +549.55% surge from the present price of $4.14.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $36.84 | $1.3935 | $52.39 | +789.96% |
| February, 2026 | $33.42 | $31.96 | $44.27 | +707.13% |
| March, 2026 | $25.23 | $24.87 | $32.93 | +509.32% |
| April, 2026 | $28.97 | $23.38 | $36.06 | +599.74% |
| May, 2026 | $26.95 | $21.34 | $32.28 | +550.97% |
| June, 2026 | $18.79 | $18.25 | $27.48 | +353.88% |
| July, 2026 | $16.22 | $14.65 | $23.58 | +291.89% |
| August, 2026 | $19.27 | $15.52 | $23.37 | +365.45% |
| September, 2026 | $15.62 | $13.28 | $25.23 | +277.25% |
| October, 2026 | $12.06 | $10.81 | $15.70 | +191.28% |
| November, 2026 | $11.81 | $9.3442 | $12.57 | +185.26% |
| December, 2026 | $9.663 | $9.023 | $12.99 | +133.41% |
Aptevo Therapeutics Inc Stock (APVO) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Aptevo Therapeutics Inc (APVO) is $8.2167, with a high forecast of $16.40 and a low forecast of $0.0365. This indicates an +98.47% increase from the last price of $4.14.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $8.4887 | $8.1848 | $10.58 | +105.04% |
| February, 2027 | $1.5844 | $1.4844 | $12.61 | -61.73% |
| March, 2027 | $2.5678 | $0.6971 | $16.40 | -37.98% |
| April, 2027 | $1.7988 | $1.4785 | $3.0953 | -56.55% |
| May, 2027 | $0.2892 | $0.0365 | $1.6911 | -93.02% |
| June, 2027 | $0.1726 | $0.0655 | $2.2918 | -95.83% |
| July, 2027 | $0.8733 | $0.1293 | $2.1706 | -78.91% |
| August, 2027 | $0.186 | $0.2776 | $1.6886 | -95.51% |
| September, 2027 | $0.1774 | $0.2323 | $0.5774 | -95.72% |
| October, 2027 | $1.0919 | $0.09 | $1.9153 | -73.62% |
| November, 2027 | $0.2712 | $0.9938 | $0.7939 | -93.45% |
| December, 2027 | $0.1422 | $0.2052 | $0.3922 | -96.57% |
Aptevo Therapeutics Inc Stock (APVO) Price Forecast for 2028
In 2028, Aptevo Therapeutics Inc (APVO) is projected to reach an average price of $2.0824, with a high projection of $3.6084 and a low estimate of $0.5564. This indicates an -49.70% fall from the last price of $4.14.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.5772 | $0.7697 | $0.5498 | -86.06% |
| February, 2028 | $0.9764 | $0.5564 | $0.6864 | -76.41% |
| March, 2028 | $0.8331 | $0.9081 | $0.9125 | -79.88% |
| April, 2028 | $0.8123 | $0.7549 | $0.7204 | -80.38% |
| May, 2028 | $1.489 | $0.5843 | $3.6084 | -64.03% |
| June, 2028 | $1.0283 | $1.2409 | $1.1663 | -75.16% |
| July, 2028 | $1.1876 | $1.0856 | $1.0776 | -71.32% |
| August, 2028 | $1.2742 | $1.1367 | $1.1349 | -69.22% |
| September, 2028 | $1.1835 | $1.1835 | $1.1588 | -71.41% |
| October, 2028 | $1.1528 | $1.1781 | $1.0108 | -72.16% |
| November, 2028 | $1.1094 | $1.1597 | $1.0994 | -73.20% |
| December, 2028 | $1.1187 | $1.1467 | $1.0924 | -72.98% |
Aptevo Therapeutics Inc Stock (APVO) Price Forecast for 2029
The 2029 price forecast for Aptevo Therapeutics Inc Stock (APVO) is $4.8905 on average, with a high prediction of $9.5937 and a low estimate of $0.1872. This represents an +18.13% increase from the previous price of $4.14.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $1.3753 | $1.0133 | $1.3453 | -66.78% |
| February, 2029 | $1.8894 | $1.8026 | $1.8616 | -54.36% |
| March, 2029 | $1.7529 | $1.7925 | $1.809 | -57.66% |
| April, 2029 | $1.7032 | $1.7282 | $1.7406 | -58.86% |
| May, 2029 | $1.6828 | $1.6435 | $1.6139 | -59.35% |
| June, 2029 | $1.5392 | $1.5481 | $1.6112 | -62.82% |
| July, 2029 | $1.4174 | $1.4229 | $1.4956 | -65.76% |
| August, 2029 | $1.2724 | $1.29 | $1.3785 | -69.27% |
| September, 2029 | $1.1693 | $1.1793 | $1.2328 | -71.76% |
| October, 2029 | $3.4191 | $1.0813 | $9.5937 | -17.41% |
| November, 2029 | $0.2828 | $0.2097 | $3.8897 | -93.17% |
| December, 2029 | $9.5264 | $0.1872 | $9.2156 | +130.11% |
Aptevo Therapeutics Inc Stock (APVO) Price Forecast for 2030
Aptevo Therapeutics Inc Stock (APVO) is expected to reach an average price of $10.72 in 2030, with a high forecast of $13.89 and a low forecast of $7.5582. This signifies an +159.02% surge from the last price of $4.14.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $8.3036 | $9.4376 | $10.16 | +100.57% |
| February, 2030 | $8.1626 | $8.6232 | $7.57 | +97.16% |
| March, 2030 | $6.9646 | $7.5582 | $7.6493 | +68.23% |
| April, 2030 | $10.08 | $8.5779 | $9.0846 | +143.55% |
| May, 2030 | $11.30 | $10.43 | $10.87 | +172.99% |
| June, 2030 | $10.59 | $11.01 | $11.18 | +155.88% |
| July, 2030 | $10.06 | $10.75 | $10.88 | +142.89% |
| August, 2030 | $10.82 | $10.19 | $9.9368 | +161.32% |
| September, 2030 | $9.324 | $9.604 | $9.5369 | +125.22% |
| October, 2030 | $11.31 | $9.4733 | $10.56 | +173.12% |
| November, 2030 | $14.25 | $11.52 | $11.60 | +244.25% |
| December, 2030 | $14.45 | $14.24 | $13.89 | +249.14% |
4.02%
0.32%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):